Oramed Signs Definitive Deal with Medicox to Commercialize Oral Insulin in South Korea
Medicox to Distribute Oramed’s Oral Insulin in South Korea , if approved Oramed to Receive Up to $18 Million in Developmental Milestones Oramed to Receive up to 15% Royalties on Gross Sales Large Market Potential: 1 in 7 Koreans Over Age 30 Has Diabetes NEW YORK , Nov.
Webinar: Highlighting Phase 2 NASH Clinical Trial Data and KOL Discussion
Oramed to Host Webinar Highlighting Detailed Safety and Efficacy Data from Its Positive Phase 2 Clinical Trial of ORMD-0801 for NASH To register for the event, please click the following link: https://touchconference.zoom.us/webinar/register/WN_dy3jzksKQA6kBKZdT5a0_g Professor Yaron Ilan, M.D., Director of the Department of Medicine at the Hebrew University-Hadassah Medical Center, and Joel Neutel, M.D., Director of Research, […]
